Angi Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Angi Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	499	736	1,132	1,326	1,468	1,619	1,764	1,359	1,185	1,031
Cost of revenue	25.9	34.1	55.7	46.5	173	275	337	62.5	57.6	47.4
Gross profit	473	702	1,077	1,280	1,295	1,345	1,427	1,296	1,128	983
Research and development	20.6	47.9	61.1	64.2	68.8	70.9	73.8	96.5	95.4	87.4
Selling and marketing	307	464	541	733	763	872	890	765	602	508
General and administrative	110	300	323	348	374	395	447	359	320	263
Operating income	24.1	-148	63.9	38.6	-6.37	-67.9	-75.6	-26.5	21.9	65.4
Interest expense	0	1.77	11.6	11.5	14.2	23.5	20.1	20.1	20.2	20.5
Interest income		0.5	4.8	8	1.7	0.24	4.53	17.1	19.6	15.7
Other non-operating income				6.49	1.22	-2.51	1.17	18.4	18.4	17.6
Pre-tax income	22.5	-154	70	33.6	-19.3	-93.9	-94.6	-28.2	20.1	62.5
Income tax	11.8	-49.1	-7.48	-1.67	-15.2	-29.9	-5.39	1.84	-16.8	18.7
Income from continuing operations						-64.9	-89.6	-30.7	36	43.8
Net income to minority interests	-2.5	-1.41	0.19	0.49	2.12	0.88	0.47	0.63	0.84	0
Net income	13.1	-103	77.3	34.8	-6.28	-71.4	-128	-40.9	36	43.8
EBITDA	32.5	-133	88.2	78.6	46.3	-8.89	1.9	67.1	108	111
EPS, basic	0.30	-2.43	1.62	0.71	-0.10	-1.42	-2.63	-0.81	0.72	0.96
EPS, diluted	0.30	-2.43	1.52	0.71	-0.10	-1.42	-2.63	-0.81	0.71	0.94
Shares, basic (weighted)	41	42.5	47.8	49.9	49.2	49.7	49.7	50.6	50	45.8
Shares, diluted (weighted)	41	42.5	50.7	51.2	49.2	49.7	49.7	50.6	50.7	46.5

Balance sheet

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	36.4	222	337	391	813	428	321	364	416	304
Short-term investments		0	24.9	0	50	0	0
Receivables	18.7	28.1	27.3	41.7	43.1	86.3	72	51.1	36.7	33.1
Other current assets	8.74	12.8	84.9	67.8	72	70.5	64.3	72.1	42	29.6
Total current assets	63.8	262	474	500	978	585	484	487	495	366
Property, plant and equipment	23.6	53.3	70.9	103	109	118	153	110	79.6	99.1
Lease right-of-use assets			0	101	87.6	69.9	56.3	46	30.4	25.3
Goodwill	171	770	895	884	892	916	883	886	883	890
Intangible assets	10.8	329	304	252	210	194	178	171	168	167
Other non-current assets	11.1	2.07	23.2	183	94.3	76.2	61.5	54.5	35.9	31.4
Total assets	296	1,467	1,808	1,922	2,368	2,012	1,908	1,856	1,831	1,680
Accounts payable	11.5	18.9	20.1	26	30.8	38.9	30.4	29.5	18.3	34
Accrued liabilities	34.4	75.2	106	117	148	186	183	179	171	166
Deferred revenue	18.8	62.4	61.4	58.2	54.7	53.2	50.1	49.9	42	22.1
Short-term debt	0	13.8	13.8	13.8	0
Total current liabilities	67.6	171	201	215	234	278	282	259	232	222
Long-term debt	0	258	245	232	712	495	495	496	497	498
Lease liabilities				119	104	88.4	72.7	51.6	35.5	24.2
Other non-current liabilities	2.25	5.89	16.8	121	112	91.7	75.5	54.3	37.9	31.4
Total liabilities	133	464	486	598	1,085	867	856	812	768	753
Total debt	0	275	261	248	712	495	495	496	497	498
Paid-in capital	0	1,112	1,333	1,357	1,379	1,350	1,405	1,447	1,466	1,428
Retained earnings	0	-122	-18.8	16	9.75	-61.6	-190	-231	-195	-151
Treasury stock			0	-57.9	-122	-158	-166	-177	-206	-356
Other comprehensive income	-1.72	2.23	-1.86	-1.38	4.64	3.31	-1.17	1.19	-2.5	5.94
Shareholders' equity	153	993	1,313	1,314	1,272	1,135	1,048	1,041	1,063	927
Minority interests	9.48	9.75	9.05	9.26	10.6	10.9	2.99	3.74	0
Total equity	163	1,003	1,322	1,324	1,283	1,146	1,051	1,045	1,063	927
Total liabilities and equity	296	1,467	1,808	1,922	2,368	2,012	1,908	1,856	1,831	1,680

Cash flow statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	13.1	-103	77.5	34.8	-6.28	-70.5	-128	-40.3	36.8	43.8
Depreciation and amortization	8.42	14.5	24.3	39.9	52.6	59	77.5	93.6	86.1	45.3
Stock-based compensation	8.92	149	97.1	68.3	83.6	28.2	50.8	43.4	34.8	14.8
Deferred income tax	-3.72	-48.4	-8.37	-3.25	-15.3	-34.2	-9.76	-10	-24	13.2
Change in receivables	-23.9	-33.2	-47.7	-79	-79.8	-107	-112	-58.2	-45.4	-43.8
Change in payables	14.9	0.78	-0.58	24.3	39.5	21.7	11.6	-8.05	-0.6	-3.83
Cash from operations	47.9	41.8	224	214	188	6.21	27.1	94.2	156	105
Capital expenditures	-16.7	-26.8	-47	-68.8	-52.5	-69.9	-115	-47.8	-50.5	-59.6
Acquisitions	-15.6	-66.3	3.67	-20.3	-2.26	-25.6	0
Purchases of investments	0	0	-59.7	0	-100	0	0	-12.4	0	0
Cash from investing	-32.3	-93.2	-57.6	-40.6	-104	-45.1	-116	-46.6	-50.4	-59.5
Debt issued	44.8	131	0	0	500	0	0
Debt repaid	-11.4	-182	-1.9
Stock issued	0	1.65	4.69	0.57	0	0	0	0
Share buybacks		0	0	-56.9	-63.7	-35.4	-8.14	-10.9	-28.6	-149
Cash from financing	29	225	-49	-122	337	-345	-17.2	-17	-53.8	-158
Exchange rate effect	-0.1	1.22	0.21	0.66	0.57	-0.05	-1.11
Net change in cash	44.5	175	117	52.7	422	-384	-107	42.2	52.2	-113
Free cash flow	31.2	15	177	145	136	-63.7	-88.4	46.4	105	45.5
Interest paid	0	0	12.1	10.3	5.37	21.5	19.4	19.4	19.4	19.4
Income taxes paid	8.82	1.7	0.33	12.2	1.79	4.65	1.55	4.96	20.9	7.55

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $5.42 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	95.7%	Gross profit / revenue.
Operating margin	-21.7%	Operating income / revenue.
EBITDA margin	-15.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-21.8%	Pre-tax income / revenue.
Net margin	-22.3%	Net income / revenue.
Return on equity (ROE)	-32.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-16.7%	Net income / average total assets.
Return on invested capital (ROIC)	-19.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	5.8%	Research and development expense / revenue.
Stock-based pay / revenue	2.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	6.6%	Capital expenditures / revenue.
D&A / revenue	6.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-13.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-16.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-6.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-12.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-11.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-5.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	198.9%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	2.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	287.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	19.1%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	21.7%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	32.4%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-32.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	57.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-11.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-56.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-19.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-12.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-4.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-6.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-8.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-4.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-6.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-8.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.20x	Current assets / current liabilities.
Quick ratio	1.05x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.88x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.58x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	30.1%	Total debt / total assets.
Liabilities / assets	48.1%	Total liabilities / total assets.
Net debt	$209.8M	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	-10.5x	Operating income / interest expense.
Working capital	$42.1M	Current assets - current liabilities.
Goodwill and intangibles / assets	61.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$131.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.75x	Revenue / average total assets.
Fixed asset turnover	10.3x	Revenue / average property, plant and equipment.
Receivables turnover	27.1x	Revenue / average receivables.
Days sales outstanding	13 days	365 x average receivables / revenue.
Days payables	321 days	365 x average accounts payable / cost of revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$5.48	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$24.53	Revenue / diluted weighted shares.
Book value per share	$17.00	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$3.25	Tangible book value / shares outstanding.
Cash per share	$4.66	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$219.8M	Share price x shares outstanding.
Enterprise value	$429.6M	Market cap + total debt - cash - short-term investments.
P/S	0.22x	Market cap / revenue.
P/B	0.32x	Market cap / shareholders' equity. Only when equity is positive.
EV/Sales	0.43x	Enterprise value / revenue.
Earnings yield	-100.9%	Net income / market cap (the inverse of P/E).
Shareholder yield	32.9%	(Dividends paid + share buybacks) / market cap.

What was Angi Inc.'s revenue in fiscal 2025?

Angi Inc. reported revenue of $1.03B for fiscal 2025, 13% lower than the year before.

Was Angi Inc. profitable in fiscal 2025?

Yes. Net income was $43.8M, a net margin of 4.3%.

How much free cash flow did Angi Inc. generate in fiscal 2025?

Cash from operations of $105.1M minus capital expenditures of $59.6M left free cash flow of $45.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Angi Inc.